DeLauro Calls on FDA, HHS to Recall Drug Commonly Found in Zantac
December 19, 2019
December 19, 2019
WASHINGTON, Dec. 19 -- Rep. Rosa L. DeLauro, D-Connecticut, issued the following news release:
Congresswoman Rosa DeLauro (CT-03) sent a letter to the Food and Drug Administration (FDA) Commissioner Stephen Hahn and the Department of Health and Human Services (HHS) Secretary Alex Azar to recall drugs containing ranitidine due to high levels of N-Nitrososdimethylamine ("NDMA"), a probable human carcinogen.
"Due to a historically very high perception of saf . . .
Congresswoman Rosa DeLauro (CT-03) sent a letter to the Food and Drug Administration (FDA) Commissioner Stephen Hahn and the Department of Health and Human Services (HHS) Secretary Alex Azar to recall drugs containing ranitidine due to high levels of N-Nitrososdimethylamine ("NDMA"), a probable human carcinogen.
"Due to a historically very high perception of saf . . .